Cargando…
Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, management and outcomes of the condition is still evolving...
Autores principales: | Garcia, Jao Jarro, Turalde, Christian Wilson, Bagnas, Marjorie Anne, Anlacan, Veeda Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118003/ https://www.ncbi.nlm.nih.gov/pubmed/33975846 http://dx.doi.org/10.1136/bcr-2021-242365 |
Ejemplares similares
-
Memantine for Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Trials
por: Turalde, Christian Wilson R., et al.
Publicado: (2021) -
Isolated Cranial Nerve VI Palsy and Neurosyphilis: A Case Report and Review of Related Literature
por: Garcia, Jao Jarro B., et al.
Publicado: (2022) -
Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011) -
Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009) -
Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014)